Rocket Pharmaceuticals Inc (RCKT)
21.86
-1.00
(-4.37%)
USD |
NASDAQ |
Jun 14, 16:00
21.86
0.00 (0.00%)
After-Hours: 20:00
Rocket Pharmaceuticals Cash from Investing (TTM): -26.31M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -26.31M |
December 31, 2023 | -98.07M |
September 30, 2023 | -65.85M |
June 30, 2023 | -90.64M |
March 31, 2023 | -43.05M |
December 31, 2022 | -69.33M |
September 30, 2022 | 56.12M |
June 30, 2022 | 14.47M |
March 31, 2022 | -14.97M |
December 31, 2021 | 18.85M |
September 30, 2021 | -52.47M |
June 30, 2021 | -98.48M |
March 31, 2021 | -153.26M |
December 31, 2020 | -96.59M |
September 30, 2020 | -18.62M |
June 30, 2020 | 80.76M |
March 31, 2020 | -40.69M |
Date | Value |
---|---|
December 31, 2019 | -39.01M |
September 30, 2019 | -43.48M |
June 30, 2019 | -81.64M |
March 31, 2019 | -62.18M |
December 31, 2018 | -5.272M |
September 30, 2018 | 51.42M |
June 30, 2018 | 54.41M |
March 31, 2018 | 161.22M |
December 31, 2017 | 75.02M |
September 30, 2017 | -43.01M |
June 30, 2017 | -38.08M |
March 31, 2017 | -53.85M |
December 31, 2016 | -66.06M |
September 30, 2016 | -26.02M |
June 30, 2016 | -60.35M |
March 31, 2016 | -44.02M |
December 31, 2015 | -31.68M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-153.26M
Minimum
Mar 2021
80.76M
Maximum
Jun 2020
-43.11M
Average
-43.26M
Median
Cash from Investing (TTM) Benchmarks
Ligand Pharmaceuticals Inc | -26.01M |
ACADIA Pharmaceuticals Inc | -174.56M |
Alnylam Pharmaceuticals Inc | -327.75M |
United Therapeutics Corp | 236.80M |
ADMA Biologics Inc | -5.398M |